Blood pressure safety of subanesthetic ketamine for depression: A report on 684 infusions
Riva-Posse, P., Reiff, C. M., Edwards, J. A., Job, G. P., Galendez, G. C., Garlow, S. J., ... & McDonald, W. M. | Journal of affective disorders | 19 July 2018
A Survey of American Psychiatrists’ Attitudes Toward Classic Hallucinogens
Barnett, B. S., Siu, W. O., & Pope Jr, H. G. | The Journal of nervous and mental disease | 1 June 2018
Key interindividual determinants in MDMA pharmacodynamics
Papaseit, E., Torrens, M., Pérez-Mañá, C., Muga, R., & Farré, M. | Expert opinion on drug metabolism & toxicology | 14 February 2018
Evaluating the abuse potential of psychedelic drugs for medical use in humans
Heal, D. J., Gosden, J., & Smith, S. L. | Neuropharmacology | 7 February 2018
Is LSD toxic?
Nichols, D. E., & Grob, C. S. | Forensic science international | 2 February 2018
Psychedelics and the essential importance of context
Carhart-Harris, R. L., Roseman, L., Haijen, E., Erritzoe, D., Branchi, I., & Kaelen, M. | Journal of Psychopharmacology | 1 February 2018
Key interindividual determinants in MDMA pharmacodynamics.
Papaseit, E., Torrens, M., Pérez-Mañá, C., Muga, R., & Farré, M. | Expert opinion on drug metabolism & toxicology | 16 January 2017
A regulatory perspective on the evaluation of hallucinogen drugs for human use
Calderon, S. N., Hunt, J., & Klein, M. | Neuropharmacology | 24 November 2017
Regulation of human research with LSD in the United States (1949-1987)
Bonson, K. R. | Psychopharmacology | 17 November 2017
Psychedelic Drugs in Biomedicine
Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V. | Trends in Pharmacological Sciences | 22 September 2017
First Time View on Human Metabolome Changes after a Single Intake of 3,4-Methylenedioxymethamphetamine in Healthy Placebo-Controlled Subjects
Boxler, M. I., Liechti, M. E., Schmid, Y., Kraemer, T., & Steuer, A. E. | Journal of proteome research | 1 September 2017
MDMA and brain activity during neurocognitive performance: An overview of neuroimaging studies with abstinent ‘Ecstasy’ users
Roberts, C. A., Quednow, B. B., Montgomery, C., & Parrott, A. C. | Neuroscience & Biobehavioral Reviews | 8 August 2017
Side-effects associated with ketamine use in depression: a systematic review
Short, B., Fong, J., Galvez, V., Shelker, W., & Loo, C. K. | The Lancet Psychiatry | 27 July 2017
Psychedelic drug use in healthy individuals: A review of benefits, costs, and implications for drug policy
Elsey, J. W. | Drug Science, Policy and Law | 26 July 2017
First time view on human metabolome changes after a single intake of 3,4 methylenedioxymethamphetamine (MDMA) in healthy placebo-controlled subjects
Boxler, M. I., Liechti, M. E., Schmid, Y., Kraemer, T., & Steuer, A. E. | Journal of Proteome Research | 19 July 2017
LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark
Larsen, J. K. | Nordic Journal of Psychiatry | 5 July 2017
Ayahuasca: what mental health professionals need to know
Santos, R. G. D., Bouso, J. C., & Hallak, J. E. C. | Archives of Clinical Psychiatry (São Paulo) | 1 July 2017
Isolated non-cardiogenic pulmonary edema – A rare complication of MDMA toxicity
Haaland, A., Warman, E., Pushkar, I., Likourezos, A., & Friedman, M. S. | The American journal of emergency medicine | 27 June 2017
Low-dose ketamine for treatment resistant depression in an academic clinical practice setting
Feifel, D., Malcolm, B., Boggie, D., & Lee, K. | Journal of affective disorders | 20 June 2017
A review on traditional uses, phytochemistry, pharmacology, pharmacokinetics and toxicology of the genus Peganum
Li, S., Cheng, X., & Wang, C. | Journal of Ethnopharmacology | 5 May 2017
Modern Clinical Research on LSD
Liechti, M. E. | Neuropsychopharmacology | 27 April 2017
Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action
Andrade, C. | The Journal of clinical psychiatry | 1 April 2017
A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders
Sanacora, G., Frye, M. A., McDonald, W., Mathew, S. J., Turner, M. S., Schatzberg, A. F., ... & Nemeroff, C. B. | Jama psychiatry | 1 April 2017
Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults
Brown, R. T., Nicholas, C. R., Cozzi, N. V., Gassman, M. C., Cooper, K. M., Muller, D., ... & Hutson, P. R. | Clinical Pharmacokinetics | 28 March 2017
Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome
Kiraly, D. D., Horn, S. R., Van Dam, N. T., Costi, S., Schwartz, J., Kim-Schulze, S., ... & Iosifescu, D. V. | Translational psychiatry | 21 March 2017